Search Results - "Gibo, Denise"
-
1
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors
Published in PloS one (16-10-2013)“…Interleukin 13 receptor alpha 2 (IL-13RA2) is over-expressed in a vast majority of human patients with high-grade astrocytomas like glioblastoma. Spontaneous…”
Get full text
Journal Article -
2
An interleukin 13 receptor α 2-specific peptide homes to human Glioblastoma multiforme xenografts
Published in Neuro-oncology (Charlottesville, Va.) (01-01-2012)“…Interleukin 13 receptor α 2 (IL-13Rα2) is a glioblastoma multiforme (GBM)-associated plasma membrane receptor, a brain tumor of dismal prognosis. Here, we…”
Get full text
Journal Article -
3
EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme
Published in Molecular cancer research (01-10-2005)“…We investigated the presence of EphA2, and its ligand, ephrinA1, in glioblastoma multiforme (GBM), a malignant neoplasm of glial cells, and normal brain. We…”
Get full text
Journal Article -
4
A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor–expressing tumor cells
Published in Molecular cancer therapeutics (01-12-2007)“…We have previously shown that the EphA2 receptor tyrosine kinase is overexpressed in glioblastoma multiforme (GBM) and represents a novel, attractive…”
Get full text
Journal Article -
5
Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy
Published in Clinical cancer research (01-01-2008)“…We investigated the expression of interleukin-13 receptor alpha2 (IL-13R alpha 2), EphA2, and Fos-related antigen 1 (Fra-1) in astrocytomas and normal brain…”
Get full text
Journal Article -
6
EphrinA1 Is Released in Three Forms from Cancer Cells by Matrix Metalloproteases
Published in Molecular and Cellular Biology (01-08-2012)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
7
Fos-Related Antigen 1 Modulates Malignant Features of Glioma Cells
Published in Molecular cancer research (01-04-2005)“…Malignant gliomas, and high-grade gliomas (HGG) in particular, are nonmetastasizing but locally infiltrating, hypervascularized brain tumors of poor prognosis…”
Get full text
Journal Article -
8
Fos-related antigen 1 (Fra-1) pairing with and transactivation of JunB in GBM cells
Published in Cancer biology & therapy (15-01-2011)“…Fos-related antigen 1 (Fra-1) plays an important role in maintenance/progression of various cancers, including glioblastoma multiforme (GBM). In this study, we…”
Get full text
Journal Article -
9
Frame-Based Stereotactic Biopsy of Canine Brain Masses: Technique and Clinical Results in 26 Cases
Published in Frontiers in veterinary science (27-07-2015)“…This report describes the methodology, diagnostic yield, and adverse events (AE) associated with frame-based stereotactic brain biopsies (FBSB) obtained from…”
Get full text
Journal Article -
10
Interleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy
Published in Clinical cancer research (01-01-2008)“…Purpose: We investigated the expression of interleukin-13 receptor α2 (IL-13Rα2), EphA2, and Fos-related antigen 1 (Fra-1) in astrocytomas and normal brain. We…”
Get full text
Journal Article -
11
Reoxygenation of Hypoxic Glioblastoma Multiforme Cells Potentiates the Killing Effect of an Interleukin-13-Based Cytotoxin
Published in Clinical cancer research (01-01-2009)“…Purpose: Hypoxia is a cause for resistance to cancer therapies. Molecularly targeted recombinant cytotoxins have shown clinical efficacy in the treatment of…”
Get full text
Journal Article -
12
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker
Published in Neuro-oncology (Charlottesville, Va.) (01-10-2012)“…Our objective was to exploit a novel ligand-based delivery system for targeting diagnostic and therapeutic agents to cancers that express interleukin 13…”
Get full text
Journal Article -
13
IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications
Published in Translational oncology (01-12-2011)“…Abstract Glioblastoma multiforme (GBM) overexpresses interleukin 13 receptor α2 (IL-13Rα2), a tumor-restricted receptor that is not present in normal brain. We…”
Get full text
Journal Article -
14
Molecular targeting of intracellular compartments specifically in cancer cells
Published in Genes & cancer (01-05-2010)“…We have implemented a strategy in which a genetically engineered, single-chain protein specifically recognizes cancer cells and is trafficked to a targeted…”
Get full text
Journal Article -
15
Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2
Published in Cancer biotherapy & radiopharmaceuticals (01-10-2008)“…High-grade astrocytoma (HGA) is an invariably fatal malignancy with a mean survival of 14 months despite surgery, radiation, and chemotherapy. We have found…”
Get more information
Journal Article -
16
Novel anti-brain tumor cytotoxins specific for cancer cells
Published in Nature biotechnology (01-05-1998)“…The vast majority of brain cancers (gliomas) express a receptor (R) for interleukin 13 (IL13). In order to achieve specific targeting of the IL13R in gliomas,…”
Get full text
Journal Article -
17
Receptor for Interleukin 13 Is a Marker and Therapeutic Target for Human High-Grade Gliomas
Published in Clinical cancer research (01-05-1999)“…Glioblastoma multiforme (GBM) is an incurable brain tumor. Due to the striking heterogeneity that characterizes GBM, there is no known tumor-specific antigen…”
Get full text
Journal Article -
18
IL-13Rα2 is a Glioma-Restricted Receptor for Interleukin-13
Published in Neoplasia (New York, N.Y.) (2002)“…We have found that binding sites for interleukin-13. ( IL13) are overexpressed in a vast majority of high-grade astrocytomas. (HGAs). These binding sites for…”
Get full text
Journal Article -
19
Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen
Published in Molecular medicine (Cambridge, Mass.) (01-05-2000)“…The vast majority of patients with high-grade gliomas (HGG) over-express interleukin 4 (IL4)-independent binding sites for IL13 in situ. In addition, mutated…”
Get full text
Journal Article -
20
BI-09EphA3 RECEPTOR IS A MOLECULAR TARGET EXPRESSED IN MULTIPLE COMPARTMENTS OF GBM
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)“…Eph receptor A3 belongs to the Eph family of receptor tyrosine kinases playing critical roles in cancer. We and others found this receptor to be over-expressed…”
Get full text
Journal Article